EUVD-2025-32483

| CVE-2025-52653 HIGH
2025-10-03 [email protected]
7.6
CVSS 3.1
Share

CVSS Vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H
Attack Vector
Network
Attack Complexity
Low
Privileges Required
Low
User Interaction
Required
Scope
Unchanged
Confidentiality
High
Integrity
Low
Availability
High

Lifecycle Timeline

3
EUVD ID Assigned
Mar 13, 2026 - 19:29 euvd
EUVD-2025-32483
Analysis Generated
Mar 13, 2026 - 19:29 vuln.today
CVE Published
Oct 03, 2025 - 18:15 nvd
HIGH 7.6

Tags

XSS Dryice Myxalytics

Description

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

Analysis

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

Technical Context

Cross-site scripting (XSS) allows injection of client-side scripts into web pages viewed by other users due to insufficient output encoding.

Affected Products

Affected products: Hcltech Dryice Myxalytics 6.6

Remediation

Encode all user-supplied output contextually (HTML, JS, URL). Implement Content Security Policy (CSP) headers. Use HTTPOnly and Secure cookie flags.

Priority Score

38
Low Medium High Critical
KEV: 0
EPSS: +0.0
CVSS: +38
POC: 0

Share

EUVD-2025-32483 vulnerability details – vuln.today
Back

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy